{"id":52524,"date":"2026-09-08T01:25:46","date_gmt":"2026-09-08T01:25:46","guid":{"rendered":"https:\/\/cp.snarskis.lt\/index.php\/2026\/09\/08\/claret-capital-partners-uzdare-575-mln-euru-fonda-augimo-skolai-europoje-jau-skirta-32-proc\/"},"modified":"2026-09-08T01:25:46","modified_gmt":"2026-09-08T01:25:46","slug":"claret-capital-partners-uzdare-575-mln-euru-fonda-augimo-skolai-europoje-jau-skirta-32-proc","status":"publish","type":"post","link":"https:\/\/cp.snarskis.lt\/index.php\/2026\/09\/08\/claret-capital-partners-uzdare-575-mln-euru-fonda-augimo-skolai-europoje-jau-skirta-32-proc\/","title":{"rendered":"\u201eClaret Capital Partners\u201c u\u017edar\u0117 575 mln. eur\u0173 fond\u0105: augimo skolai Europoje jau skirta 32 proc."},"content":{"rendered":"<p>Rizikos skolos ir augimo finansavimo bendrov\u0117 \u201eClaret Capital Partners\u201c u\u017edar\u0117 ketvirt\u0105j\u012f Europos augimo kapitalo fond\u0105, kurio dydis siekia 575 mln. eur\u0173. Tai vir\u0161ijo anks\u010diau skelbt\u0105 500 mln. eur\u0173 tiksl\u0105, o fondas bus skirtas Europos technologij\u0173, gyvyb\u0117s moksl\u0173 ir poveik\u012f kurian\u010dioms \u012fmon\u0117ms.<\/p>\n<p>Pasak bendrov\u0117s, kartu su susijusiais diskreciniais mandat\u0173 portfeliais fondas investuos \u012f augimo skol\u0105, kuri paprastai leid\u017eia \u012fmon\u0117ms pritraukti kapital\u0105 su ma\u017eesniu nuosavyb\u0117s dalies praskiedimu nei renkantis vien akcij\u0173 finansavim\u0105. Tokios l\u0117\u0161os da\u017eniausiai naudojamos tarptautinei pl\u0117trai, \u012fsigijimams ir produkt\u0173 k\u016brimui.<\/p>\n<h2>Kur bus nukreiptos investicijos?<\/h2>\n<p>\u201eClaret Capital Partners\u201c nurodo, kad jau yra investavusi 32 proc. fondo kapitalo ir parem\u0117 daugiau nei 27 bendroves. Tarp j\u0173 minimos B2B atid\u0117to mok\u0117jimo platforma \u201eBillie\u201c, klinikin\u0117s stadijos farmacijos \u012fmon\u0117 \u201eCinclus Pharma\u201c, komercinio nekilnojamojo turto programin\u0117s \u012frangos tiek\u0117ja \u201ePRODA\u201c, biotechnologij\u0173 bendrov\u0117 \u201eInventiva\u201c ir pardavim\u0173 analitikos platforma \u201eSurfe\u201c.<\/p>\n<p>Tokie sandoriai atspindi pastar\u0173j\u0173 met\u0173 tendencij\u0105 Europos rinkoje, kai spar\u010diai augan\u010dios \u012fmon\u0117s vis da\u017eniau ie\u0161ko alternatyv\u0173 vien akcij\u0173 finansavimui. Augimo skola paprastai pasirenkama tuomet, kai \u012fmon\u0117 nori i\u0161laikyti didesn\u0119 kontrol\u0119 ir i\u0161vengti didesnio praskiedimo, ta\u010diau vis tiek finansuoti spartesn\u012f mastelio didinim\u0105.<\/p>\n<h2>Kod\u0117l auga augimo skolos paklausa?<\/h2>\n<p>\u201eClaret Capital Partners\u201c teigia, kad susidom\u0117jim\u0105 tokio tipo finansavimu skatina selektyvesn\u0117s akcij\u0173 rinkos ir didesnis investuotoj\u0173 atsargumas vertinant \u012fmoni\u0173 augimo trajektorijas. D\u0117l to daliai bendrovi\u0173 rizikos kapitalo raundai tampa ilgesni, o s\u0105lygos grie\u017etesn\u0117s, tod\u0117l skolos instrumentai \u012fgauna didesn\u012f svor\u012f finansavimo strukt\u016broje.<\/p>\n<p>Fondo galutiniame pritraukime dalyvavo instituciniai investuotojai, \u012fskaitant pensij\u0173 fondus, draudikus, \u0161eimos biurus ir vie\u0161\u0105sias institucijas, taip pat privat\u016bs investuotojai per ELTIF strukt\u016br\u0105. Bendrov\u0117 taip pat planuoja naudotis bendro investavimo partneryst\u0117mis, kad gal\u0117t\u0173 dalyvauti didesn\u0117s apimties sandoriuose.<\/p>\n<p>\u201eTur\u0117dami augant\u012f auk\u0161tos kokyb\u0117s galimybi\u0173 sraut\u0105, aktyviai investuojame ir toliau ie\u0161kome verslinink\u0173, kurian\u010di\u0173 kit\u0105 Europos \u010dempion\u0173 kart\u0105\u201c, \u2013 sak\u0117 \u201eClaret Capital Partners\u201c vadovaujantis partneris Davidas Batemanas.<\/p>\n<p>Fondo u\u017edarymas seka po ankstesnio 297 mln. eur\u0173 fondo, kuris galutinai suformuotas 2022 metais. Bendrov\u0117 nurodo, kad jos portfelis v\u0117liau fiksavo pasitraukimus, tarp j\u0173 Cytora \u012fsigijim\u0105, Endomag \u012fsigijim\u0105, Logpoint \u012fsigijim\u0105, Lyst \u012fsigijim\u0105, Tiqets \u012fsigijim\u0105 ir Abivax vie\u0161\u0105 akcij\u0173 si\u016blym\u0105 \u201eNasdaq\u201c bir\u017eoje.<\/p>\n<p>\u201eKadangi akcij\u0173 rinkos i\u0161lieka selektyvesn\u0117s, o \u012fk\u016br\u0117jai ie\u0161ko b\u016bd\u0173 augti be nereikalingo praskiedimo, tikim\u0117s, kad lanks\u010dios, nuosavyb\u0117s nedilutuojan\u010dios kapitalo formos paklausa ir toliau spart\u0117s\u201c, \u2013 sak\u0117 \u201eClaret Capital Partners\u201c vadovaujantis partneris Johanas Kampe.<\/p>\n<p>\u201eClaret Capital Partners\u201c teigia per visus fond\u0173 laikotarpius investavusi daugiau nei 1,5 mlrd. eur\u0173 \u012f daugiau nei 210 bendrovi\u0173, \u012fskaitant perdirbt\u0105 kapital\u0105. Po naujo fondo u\u017edarymo bendrov\u0117 planuoja pl\u0117sti veikl\u0105 Europoje, stiprindama komand\u0105 Pary\u017eiuje ir planuodama buvim\u0105 Berlyne.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201eClaret Capital Partners\u201c u\u017edar\u0117 575 mln. eur\u0173 augimo skolos fond\u0105 Europai ir jau investavo 32 proc. kapitalo \u012f daugiau nei 27 bendroves.<\/p>\n","protected":false},"author":0,"featured_media":52525,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[40620,40619,40665,5350,83,40621,450],"miestas":[],"class_list":["post-52524","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technologijos","tag-augimo-skola","tag-claret-capital-partners","tag-eltif","tag-europos-startuoliai","tag-fintech","tag-gyvybes-mokslai","tag-rizikos-kapitalas"],"acf":[],"_links":{"self":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts\/52524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/comments?post=52524"}],"version-history":[{"count":0,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts\/52524\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/media\/52525"}],"wp:attachment":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/media?parent=52524"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/categories?post=52524"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/tags?post=52524"},{"taxonomy":"miestas","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/miestas?post=52524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}